Citigroup’s Biofrontera BFRI Stock Holding History
Bought
Maintained
Sold
Other funds holding BFRI
RA
ACM
VFT
VCM
XT
SA
Citigroup's BFRI Position: Q1 2026 in Review
Citigroup increased its Biofrontera (BFRI) stake by 1,183,600% in Q1 2026, buying an estimated $10.2K and bringing the position to 11,837 shares worth $9.58K. The position accounts for ﹤0.01% of the portfolio, ranked #5058.
Citigroup first reported a position in BFRI in Q1 2022 and has held it in 5 quarters since. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2026.
- Citigroup held 11,837 shares of Biofrontera worth $9.58K as of Q1 2026.
- Citigroup bought 11,836 Biofrontera shares in Q1 2026, an estimated $10.2K.
- Biofrontera made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5058 holding.
- Citigroup first reported a position in Biofrontera in Q1 2022 and has held it in 5 quarters since.
- 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.